Independent Research Confirms >$10bn Market Opportunity for POLB 001 as a Preventative Therapy for Cancer Immunotherapy-Induced Cytokine Release Syndrome (CRS)Former…
The FDA has accepted a New Drug Application filed by Lykos Therapeutics for MDMA-assisted therapy for PTSD The application was…
MacNaughton to Lead Business into Enterprise-first EraNEW YORK--(BUSINESS WIRE)--Please replace the release dated February 8, 2024 with the following corrected…
PharmAla will consult on GMP Drug Product and Regulatory Development for Red Light Holland Toronto, Ontario--(Newsfile Corp. - February 9,…
Fort Lee, NJ, Feb. 09, 2024 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or the "Company"), a clinical-stage…
PharmAla will consult on GMP Drug Product and Regulatory Development for Red Light HollandVANCOUVER, British Columbia, Feb. 09, 2024 (GLOBE…
– BLA submission supported by results from Phase 2/3 clinical trial and outcomes of real-world use of the HAV under…
News of the Successful Trial Comes Amid an Oversubscribed Investor Round and Preparation for Series A Financing RoundRALEIGH, NC /…
MacNaughton to Lead Business into Enterprise-first Era, with OptumRx as Strategic PartnerNEW YORK--(BUSINESS WIRE)--Calibrate, the leading clinician-guided and value-based obesity…
NASHVILLE, TN / ACCESSWIRE / February 8, 2024 / Profound Research, a leading clinical trial site network, today announced key…